These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


295 related items for PubMed ID: 9176537

  • 1. Effect of cyclosporin A on the allergen-induced late asthmatic reaction.
    Sihra BS, Kon OM, Durham SR, Walker S, Barnes NC, Kay AB.
    Thorax; 1997 May; 52(5):447-52. PubMed ID: 9176537
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of a bronchial provocation test with house-dust mite on blood eosinophilia, eosinophil cationic protein, soluble interleukin-2 receptor, and interleukin-6 in asthmatic children.
    Van Bever HP, Moens MM, Bridts CH, De Clerck LS, Mertens AV, Bosmans E, Stevens WJ.
    Allergy; 1993 Aug; 48(6):443-9. PubMed ID: 8238800
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma.
    Evans DJ, Barnes PJ, Spaethe SM, van Alstyne EL, Mitchell MI, O'Connor BJ.
    Thorax; 1996 Dec; 51(12):1178-84. PubMed ID: 8994512
    [Abstract] [Full Text] [Related]

  • 9. Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial.
    Beeh KM, Beier J, Meyer M, Buhl R, Zahlten R, Wolff G.
    Pulm Pharmacol Ther; 2006 Dec; 19(4):233-41. PubMed ID: 16140027
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers.
    Parameswaran K, Inman MD, Watson RM, Morris MM, Efthimiadis A, Ventresca PG, Lam R, O'Byrne PM, Hargreave FE.
    Can Respir J; 2000 Dec; 7(4):313-9. PubMed ID: 10980457
    [Abstract] [Full Text] [Related]

  • 12. Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005.
    Hamilton AL, Watson RM, Wyile G, O'Byrne PM.
    Thorax; 1997 Apr; 52(4):348-54. PubMed ID: 9196518
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A comparison of the effects of oral cetirizine and inhaled beclomethasone on early and late asthmatic responses to allergen and the associated increase in airways hyperresponsiveness.
    Bentley AM, Walker S, Hanotte F, De Vos C, Durham SR.
    Clin Exp Allergy; 1996 Aug; 26(8):909-17. PubMed ID: 8877156
    [Abstract] [Full Text] [Related]

  • 18. Attenuation of the allergen-induced late asthmatic reaction by cyclosporin A is associated with inhibition of bronchial eosinophils, interleukin-5, granulocyte macrophage colony-stimulating factor, and eotaxin.
    Khan LN, Kon OM, Macfarlane AJ, Meng Q, Ying S, Barnes NC, Kay AB.
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1377-82. PubMed ID: 11029348
    [Abstract] [Full Text] [Related]

  • 19. Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: relationship to the development of late asthmatic responses.
    Wenzel SE, Westcott JY, Larsen GL.
    J Allergy Clin Immunol; 1991 Feb; 87(2):540-8. PubMed ID: 1993813
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.